EKF Diagnostics Holdings plc (AIM:EKF)
London
· Delayed Price · Currency is GBP · Price in GBX 26.15
+0.10 (0.38%)
At close: Mar 6, 2026
EKF Diagnostics Holdings Revenue
EKF Diagnostics Holdings had revenue of 25.24M GBP in the half year ending June 30, 2025, a decrease of -6.08%. This brings the company's revenue in the last twelve months to 50.22M, down -1.43% year-over-year. In the year 2024, EKF Diagnostics Holdings had annual revenue of 50.19M, down -4.59%.
Revenue (ttm)
50.22M
Revenue Growth
-1.43%
P/S Ratio
2.25
Revenue / Employee
169.09K
Employees
297
Market Cap
112.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 50.19M | -2.42M | -4.59% |
| Dec 31, 2023 | 52.61M | -14.02M | -21.05% |
| Dec 31, 2022 | 66.64M | -15.20M | -18.57% |
| Dec 31, 2021 | 81.84M | 16.58M | 25.40% |
| Dec 31, 2020 | 65.26M | 20.34M | 45.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Scancell Holdings | 4.71M |
| Diaceutics | 34.40M |
| Shield Therapeutics | 30.29M |
| INSPECS Group | 195.28M |